HealthEquity Announces Record HSA Sales Outlook, Presentation at J.P. Morgan Healthcare Conference
January 09 2023 - 09:00AM
GlobeNewswire Inc.
HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”),
the nation’s largest health savings account (“HSA") custodian,
today announced estimates of HSAs, HSA assets and total accounts
for its fiscal year ending January 31, 2023, reflecting record new
openings and custodial asset growth.
- Estimated HSAs are expected to be
approximately 8 million by January 31, 2023, up from 7.2 million a
year earlier.
- Estimated HSA assets are expected to
be approaching $22 billion, up from $19.6 billion at the end of
fiscal year 2022. Invested balances are subject to market
fluctuation.
- Estimated total accounts are
expected to be approaching 15 million compared to 14.4 million at
the end of fiscal year 2022, not including suspended commuter
accounts.
The Company estimates that it will end its fiscal 2023 year with
more than 120,000 employer clients and over 200 network partners
consisting of integrated health and retirement plan partners,
brokers and benefit advisors.
Commenting on the results, Jon Kessler, President and CEO said,
“Team Purple and our partner ecosystem are on track to deliver
back-to-back record-breaking sales years with approximately 950,000
new HSAs from sales this year. We look forward to finishing fiscal
year 2023 strong as we welcome many new members to HealthEquity.
Increasing member HSA assets and rising interest rates are expected
to drive continued growth for fiscal 2024 and beyond.”
HealthEquity will discuss these results and estimates during a
presentation by Jon Kessler, President and CEO, at the 41st Annual
J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023,
at 9:45 am Pacific Time in the Borgia Room of the St. Francis
Hotel.
A live audio webcast of the presentation along with a copy of
the presentation slides will be available and archived on
HealthEquity’s investor relations website at
http://ir.healthequity.com.
About HealthEquity
HealthEquity and its subsidiaries administer HSAs and other
consumer-directed benefits for our more than 14 million accounts in
partnership with employers, benefits advisors, and health and
retirement plan providers who share our mission to connect health
and wealth and value our culture of remarkable “Purple” service.
For more information, visit www.healthequity.com.
Forward-looking statements
This press release contains “forward-looking statements” within
the meaning of the “safe harbor” provisions of the Private
Securities Litigation Reform Act of 1995, including but not limited
to, statements regarding our industry, business strategy, plans,
goals and expectations concerning our markets and market position,
product expansion, future operations, expenses and other results of
operations, revenue, margins, profitability, acquisition synergies,
future efficiencies, tax rates, capital expenditures, liquidity and
capital resources and other financial and operating information.
When used in this discussion, the words “may,” “believes,”
“intends,” “seeks,” “aims,” “anticipates,” “plans,” “estimates,”
“expects,” “should,” “assumes,” “continues,” “could,” “will,”
“future” and the negative of these or similar terms and phrases are
intended to identify forward-looking statements in this press
release.
Forward-looking statements reflect our current expectations
regarding future events, results or outcomes. These expectations
may or may not be realized. Although we believe the expectations
reflected in the forward-looking statements are reasonable, we can
give you no assurance these expectations will prove to be correct.
Some of these expectations may be based upon assumptions, data or
judgments that prove to be incorrect. Actual events, results and
outcomes may differ materially from our expectations due to a
variety of known and unknown risks, uncertainties and other
factors. Although it is not possible to identify all of these risks
and factors, they include, among others, risks related to the
following:
- the impact of societal and economic
changes arising out of the COVID-19 pandemic on the Company, its
operations and its financial results;
- our ability to realize the anticipated
financial and other benefits from combining the operations of
recent and future acquisitions with our business successfully;
- our ability to compete effectively in a
rapidly evolving healthcare and benefits administration
industry;
- our dependence on the continued
availability and benefits of tax-advantaged health savings accounts
and other consumer-directed benefits;
- our ability to successfully identify,
acquire and integrate additional portfolio purchases or acquisition
targets;
- the significant competition we face and
may face in the future, including from those with greater resources
than us;
- our reliance on the availability and
performance of our technology and communications systems;
- potential future cybersecurity breaches
of our technology and communications systems and other data
interruptions, including resulting costs and liabilities,
reputational damage and loss of business;
- the current uncertain healthcare
environment, including changes in healthcare programs and
expenditures and related regulations;
- our ability to comply with current and
future privacy, healthcare, tax, ERISA, investment adviser and
other laws applicable to our business;
- our reliance on partners and
third-party vendors for distribution and important services;
- our ability to develop and implement
updated features for our technology and communications systems and
successfully manage our growth;
- our ability to protect our brand and
other intellectual property rights; and
- our reliance on our
management team and key team members.
For a detailed discussion of these and other risk factors,
please refer to the risks detailed in our filings with the
Securities and Exchange Commission, including, without limitation,
our Annual Report on Form 10-K for the fiscal year ended January
31, 2022, our Quarterly Report on Form 10-Q for the quarter ended
April 30, 2022, and subsequent periodic and current reports. Past
performance is not necessarily indicative of future results. We
undertake no intention or obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise. Forward-looking statements should not
be relied upon as representing our views as of any date subsequent
to the date of this press release.
Investor Relations Contact:Richard
Putnam801-727-1209rputnam@healthequity.com
HealthEquity (NASDAQ:HQY)
Historical Stock Chart
From Feb 2023 to Mar 2023
HealthEquity (NASDAQ:HQY)
Historical Stock Chart
From Mar 2022 to Mar 2023